Publications

Using pharmacy-to-pharmacy marketplaces? Read this Suspicious Sales Surveillance Report March 24, 2026 Online pharmacy-to-pharmacy marketplaces help pharmacies with inventory management, but they also carry a higher risk of being exploited by criminals selling black market medicines that are a threat to American patients. Because of that, pharmacies who use these ...

Update on drug importation, February 2026 For over 25 years, well-meaning advocates have proposed importing unauthenticated medicine from foreign countries' drug supplies to lower prices for Americans. Past efforts didn't pay off financially and raised public health risks, but legislatures continue to consider state importation schemes while individual employers are ...

Prescription drug freight fraud report, January 2026 In November and December 2025, thousands of shipments of drugs that have been popularized by social media were imported into the United States, along with rivaroxaban (Xarelto) and antibiotics. They were imported into the country with a wide range of product code classifications, ...

Pill press update: July 2025 through January 2026 February 10, 2026 Policymakers became generally aware of pill presses with the rise of the opioid crisis, when drug traffickers began selling counterfeit prescription pills made with fentanyl, with catastrophic results. Illegal pill presses and molds continue to create fake pills that ...

Employers, do you know how much you're paying PBMs? Pharmacy benefit managers (PBM) tactics have increased costs for patients and healthcare purchasers all while driving community pharmacies out of business and failing to deliver on their promise to lower medication costs. Learn more about these tactics and what states are ...

Why are price caps a bad solution for medicine affordability? Americans need affordable access to medicines, but upper payment limits (UPLs) set by prescription drug affordability boards and Medicare Maximum Fair Prices (MFPs) are not viable solutions. In our complex drug supply chain, these price caps could bankrupt pharmacies and ...

Prescription Drug Freight Fraud Report, November 2025 Our latest analysis of FDA import records shows a continuation of the troubling patterns we've been documenting since February. From September 1 to October 31, 2025, large-scale freight fraud involving GLP-1s, oncology drugs, and other high-demand pharmaceuticals continued unabated, and in several areas ...

INTELLIGENCE ALERT: Distribution of unregulated, uninspected, unsanitary and potentially unsafe diabetes and weight loss injectables through unlicensed med spas poses immediate threat to public safety Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients inyour state may be receiving weight loss injectables from unlicensed sources that ...

Publication: Threats to HIV patients from criminals in the drug supply chain Since 2019, federal prosecutors, drug manufacturers, and patient safety organizations have uncovered extensive criminal schemes targeting HIV medicines at every point in the supply chain. These schemes undermine trust in the healthcare system, and they endanger patients. Read ...

Prescription drug freight fraud, October 2025 Our analysis of large-scale commercial imports of semaglutide, tirzepatide, apixaban, pembrolizumab, and antibiotics from March to August of 2025 showed cancer drugs masquerading as antibiotics, semaglutide supposedly manufactured at a home hardware store, and over 120 kilograms of tirzepatide from unregistered facilities marked for ...